Current Report Filing (8-k)
March 17 2020 - 1:43PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
March 17, 2020
Date of Report (Date of earliest event
reported)
iFresh Inc.
(Exact Name of Registrant as Specified
in its Charter)
Delaware
|
|
001-38013
|
|
82-066764
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
2-39 54th Avenue
Long Island City, NY
|
|
11101
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s telephone number, including
area code: (718) 628-6200
(Former name or former address, if changed
since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each
class
|
|
Trading Symbol(s)
|
|
Name of each
exchange on which registered
|
Common Stock, par value $0.0001
|
|
IFMK
|
|
Nasdaq Capital Market
|
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR §240.12b-2).
Emerging growth
company ☒
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
On March 17, 2020, iFresh Inc. (the “Company”)
entered into a purchase agreement (the “Acquisition Agreement”) with Guo Hui Ji, a citizen of the People’s Republic
of China (the “Seller”) and Xiamen DL Medical Technology Co, Ltd., a People’s Republic of China company, pursuant
to which the Seller will sell his 70% equity interests in Xiamen DL Medical Technology Co, Ltd. to the Company (the “Equity
Interests”). In consideration for the Equity Interests, the Company shall pay to the Seller $600,000 in cash and issue 900,000
shares of common stock of the Company to the Seller. The closing of the acquisition is subject to customary terms and conditions
as set forth in the Acquisition Agreement.
Item 8.01 Other Events.
On March 17, 2020, the Company issued a press release announcing
it had signed the aforesaid Acquisition Agreement. A copy of such press release is attached to this report as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 17, 2020
iFRESH, INC.
|
|
|
|
|
By:
|
/s/ Long Deng
|
|
Name:
|
Long Deng
|
|
Title:
|
Chief Executive Officer
|
|
2
iFresh (NASDAQ:IFMK)
Historical Stock Chart
From Jun 2024 to Jul 2024
iFresh (NASDAQ:IFMK)
Historical Stock Chart
From Jul 2023 to Jul 2024